Literature DB >> 12560071

BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells.

Fabíola Traina1, José Barreto C Carvalheira, Mario J A Saad, Fernando F Costa, Sara T O Saad.   

Abstract

In the present study we used K562 cells to demonstrate that insulin receptor substrate 1 (IRS-1) is expressed and constitutively phosphorylated in BCR-ABL(+) cells. We observed association between BCR-ABL/IRS-1, IRS-1/phosphoinositide 3'-kinase (PI3-kinase), and IRS-1/Grb2 in the K562 cell line. Our findings demonstrate that imatinib treatment resulted in marked attenuation of BCR-ABL/IRS-1 association and of IRS-1-stimulated PI3-kinase activity in K562 cells. We concluded that the IRS-1 protein is involved in the signalling pathway of the BCR-ABL tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560071     DOI: 10.1016/s0014-5793(02)03845-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Antineoplastic effect of rapamycin is potentiated by inhibition of IRS-1 signaling in prostate cancer cells xenografts.

Authors:  Josenilson C Oliveira; Kellen K Souza; Marília M Dias; Marcel C Faria; Eduardo R Ropelle; Marcelo B S Flores; Mirian Ueno; Lício A Velloso; Sara T Saad; Mario J A Saad; José B C Carvalheira
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-09       Impact factor: 4.553

2.  IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.

Authors:  Paula de Melo Campos; João A Machado-Neto; Christopher A Eide; Samantha L Savage; Renata Scopim-Ribeiro; Adriana da Silva Souza Duarte; Patricia Favaro; Irene Lorand-Metze; Fernando F Costa; Cristina E Tognon; Brian J Druker; Sara T Olalla Saad; Fabiola Traina
Journal:  Oncotarget       Date:  2016-02-09

3.  De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.

Authors:  Matheus Rodrigues Lopes; João Kleber Novais Pereira; Paula de Melo Campos; João Agostinho Machado-Neto; Fabiola Traina; Sara T Olalla Saad; Patricia Favaro
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

Review 4.  Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Bruna Alves Fenerich; Ana Paula Nunes Rodrigues Alves; Jaqueline Cristina Fernandes; Renata Scopim-Ribeiro; Juan Luiz Coelho-Silva; Fabiola Traina
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

5.  Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.

Authors:  Swarajit K Biswas; Yan Zhao; Lakshman Sandirasegarane
Journal:  Mol Vis       Date:  2009-08-15       Impact factor: 2.367

6.  Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice.

Authors:  Myoung Sook Han; Kun Wook Chung; Hyae Gyeong Cheon; Sang Dal Rhee; Chang-Hwan Yoon; Moon-Kyu Lee; Kwang-Won Kim; Myung-Shik Lee
Journal:  Diabetes       Date:  2009-02       Impact factor: 9.461

7.  CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.

Authors:  Rita de Cássia Carvalho Melo; Ana Leda Longhini; Carolina Louzão Bigarella; Mariana Ozello Baratti; Fabiola Traina; Patrícia Favaro; Paula de Melo Campos; Sara Teresinha Olalla Saad
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.